P30004
1-苯基哌嗪
≥97.0%
别名:
N-苯基哌嗪
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C10H14N2
化学文摘社编号:
分子量:
162.23
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
202-165-6
Beilstein/REAXYS Number:
132157
MDL number:
Assay:
≥97.0%
产品名称
1-苯基哌嗪, ≥97.0%
InChI key
YZTJYBJCZXZGCT-UHFFFAOYSA-N
InChI
1S/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H2
SMILES string
C1CN(CCN1)c2ccccc2
assay
≥97.0%
refractive index
n20/D 1.588 (lit.)
bp
286 °C (lit.)
density
1.062 g/mL at 25 °C (lit.)
Quality Level
Gene Information
mouse ... Htr3a(15561)
rat ... Drd2(24318), Htr1a(24473)
正在寻找类似产品? 访问 产品对比指南
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Dermal - Acute Tox. 3 Oral - Eye Dam. 1 - Skin Corr. 1B
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
284.0 °F
flash_point_c
140 °C
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Romano Di Fabio et al.
Journal of medicinal chemistry, 52(10), 3238-3247 (2009-04-25)
In an effort to discover novel druglike NK(1) receptor antagonists a new series of suitably substituted C-phenylpiperazine derivatives was identified by an appropriate chemical exploration of related N-phenylpiperazine analogues, with the specific aim to maximize their in vitro affinity and
Rodolfo do Couto Maia et al.
Expert opinion on therapeutic patents, 22(10), 1169-1178 (2012-09-11)
The N-phenylpiperazine subunit represents one of the most versatile scaffolds used in the medicinal chemistry field. Recently, some N-phenylpiperazine derivatives have reached late stage clinical trials for the treatment of CNS disorders, thus, this is clearly a molecular template that
Azza A Shoukry et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 96, 586-593 (2012-08-07)
With the purpose of evaluating the ability of Pd(II) complex to interact with DNA molecule as the main biological target, two new complexes [Pd(bpy)(OH(2))(2)] (1) and [Pd(Phenpip)(OH(2))(2)] (2), where (bpy=2,2'-bipyridine; Phenpip=1-phenylpiperazine), have been synthesized and the binding properties of these
Gilda Neves et al.
Pharmacology, biochemistry, and behavior, 89(1), 23-30 (2007-12-18)
Previous studies have demonstrated that LASSBio-579 and LASSBio-581, two N-phenylpiperazine derivatives designed for the treatment of schizophrenia, are presynaptic dopamine D(2) receptor agonists that induce a hypothermic effect in mice that is not mediated by dopamine receptor activation. The aim
Jadwiga Handzlik et al.
Bioorganic & medicinal chemistry, 20(7), 2290-2303 (2012-03-03)
An association between α(1)-adrenoceptor affinities, hERG K(+)-antagonistic properties and antiarrhythmic activities for a series of phenylpiperazine derivatives of hydantoin (2a-21a) was investigated. New compounds were synthesized and tested for their affinity for α(1)-adrenoceptors in radioligand binding assay using [(3)H]-prazosin as
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持